Sentence examples for mortality reduction caused from inspiring English sources

Our study suggests that the breast cancer mortality reduction caused by present-day practice of adjuvant tamoxifen and chemotherapy is 7%.

Varying lead time, survival, and mortality reduction caused the minimum of the harm benefit ratio M to vary from 1.2 to 2.4 and the maximum to vary from 20.3 to 44.0 (Table 3).

As they point out, this may be due to the diminished power of the trial (60% to detect a 20% mortality reduction) caused by a smaller than planned sample and a lower than anticipated mortality from breast cancer in the control group, which is probably due to improvements in treatment and consequent survival.

Therefore, we performed a systematic review and meta-analysis of prospective studies to answer the following question: Is the administration of systemic antibiotics at the time of intubation superior to placebo or no prophylaxis in preventing VAP and decreasing all-cause mortality reduction in comatose patients?

Others have also found that the relationship for stroke reduction is stronger than that for cardiovascular mortality or all-cause mortality reduction [ 24].

The analysis reported an adjusted long-term all-cause mortality reduction of 40% in the surgical group.

In comparison, using the same stroke data sets, no STEs could be estimated for cardiovascular (CV) mortality or all-cause mortality reduction, although the STE for CV mortality approached 25 mmHg for systolic blood pressure.

Additional attention has been given to rates of all-cause mortality reduction within the framework of Millennium Development Goal 4 (1) and considerable successes are being achieved in various countries.

79 In a recent meta-analysis, all-cause mortality reduction in hypertensive patients was driven primarily by ACEIs compared to ARBs.

Aliskiren's effect on outcomes such as all-cause mortality, reduction in cardiovascular mortality, and reduction in cardiovascular events in patients with mild-to-moderate essential hypertension as well as in special patient populations, remains to be determined.

Recently, the IN-TIME landmark trial showed a reduced risk for a worsened clinical composite score combining death, hospitalization for heart failure, NYHA class, and patient global self-assessment in remotely monitored heart failure patients with ICDs and CRT-Ds, along with all-cause mortality reduction after one year.